{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:14:06Z","timestamp":1756383246258},"reference-count":20,"publisher":"Nihon University School of Dentistry","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Oral Sci","Journal of Oral Science"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2334\/josnusd.18-0164","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T22:03:18Z","timestamp":1560895398000},"page":"386-390","source":"Crossref","is-referenced-by-count":2,"title":["Oral surgery in patients with antiphospholipid syndrome"],"prefix":"10.2334","volume":"61","author":[{"given":"Kohei","family":"Okuyama","sequence":"first","affiliation":[{"name":"Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Division of Oral and Maxillofacial Surgery, Department of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Naruse","sequence":"additional","affiliation":[{"name":"Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Yutori","sequence":"additional","affiliation":[{"name":"Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Souichi","family":"Yanamoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Clinical Oral Oncology, Nagasaki University Graduate School of Biomedical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1160","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GR (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332, 993-997.","DOI":"10.1056\/NEJM199504133321504"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT et al. (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46, 1019-1027.","DOI":"10.1002\/art.10187"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Heamost 4, 295-306.","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Cervera R (2017) Antiphospholipid syndrome. Thromb Res 151 Suppl 1, S43-47.","DOI":"10.1016\/S0049-3848(17)30066-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Cervera R, Asherson RA, Acevedo ML, G\u00f3mez-Puerta JA, Espinosa G, De La Red G et al. (2004) Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63, 1312-1317.","DOI":"10.1136\/ard.2003.014175"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. G\u00f3mez-Puerta JA, Cervera R, Espinosa G, Aguil\u00f3 S, Bucciarelli S, Ramos-Casals M et al. (2006) Antophospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 35, 322-332.","DOI":"10.1016\/j.semarthrit.2005.07.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Cervera R, Espinosa G, Bucciarelli S, G\u00f3mez-Puerta JA, Font J (2006) Lessons from the catastrophic antiphospholipid syndrome (CAPS) registry. Autoimmun Rev 6, 81-84.","DOI":"10.1016\/j.autrev.2006.06.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rodr\u00edguez-Pint\u00f3 I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G et al. (2016) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS registry. Autoimmun Rev 15, 1120-1124.","DOI":"10.1016\/j.autrev.2016.09.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lillis T, Ziakas A, Koshinas K, Tsirlis A, Giannoglou G (2011) Safety of dental extractions during uninterrupted single or dual antiplatelet treatment. Am J Cardiol 108, 964-967.","DOI":"10.1016\/j.amjcard.2011.05.029"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Olmos-Carrasco O, Pastor-Ramos V, Espinilla-Branco R, Ortiz-Z\u00e1rate A, Garc\u00eda-Avila I, Rodr\u00edguez-Alonso E et al. (2015) Hemorrhagic complications of dental extractions in 181 patients undergoing double antiplatelet therapy. J Oral Maxillofac Surg 73, 203-210.","DOI":"10.1016\/j.joms.2014.08.011"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yanamoto S, Hasegawa T, Rokutanda S, Komori S, Tachibana A, Kojima Y et al. (2017) Multicenter retrospective study of the risk factors of haemorrhage after tooth extraction in patients receiving antiplatelet therapy. J Oral Maxillofac Surg 75, 1338-1343.","DOI":"10.1016\/j.joms.2017.02.023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Espinosa G, Cervera R (2010) Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol 6, 296-300.","DOI":"10.1038\/nrrheum.2010.47"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Giannakopoulos B, Krilis SA (2013) The pathogenesis of the antiphospholipid syndrome. N Engl J Med 368, 1033-1044.","DOI":"10.1056\/NEJMra1112830"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Gorki H, Malinovski V, Stanbridge RD (2008) The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg 33, 168-181.","DOI":"10.1016\/j.ejcts.2007.11.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Erdozain JG, Ruiz-Irastorza G, Segura MI, Amigo MC, Espinosa G, Pomar JL et al. (2012) Cardiac valve replacement in patients with antiphospholipid syndrome. Arthritis Care Res (Hoboken) 64, 1256-1260.","DOI":"10.1002\/acr.21670"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sharma VK, Chaturvedi R, Manoj Luthra V (2011) Antiphospholipid syndrome, cardiac surgery and cardiopulmonary bypass. Ann Card Anaesth 14, 146-149.","DOI":"10.4103\/0971-9784.81571"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Gonz\u00e1lez-Moreno J, Callejas-Rubio JL, R\u00edos-Fern\u00e1ndez R, Ortego-Centeno N (2015) Antiphospholipid syndrome, antiphospholipid antibodies and solid organ transplantation. Lupus 24, 1356-1363.","DOI":"10.1177\/0961203315595129"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ruiz-Irastorza G, Cuadrado MJ, Ruiz-Arruza I, Brey R, Crowther M, Derksen R et al. (2011) Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus 20, 206-218.","DOI":"10.1177\/0961203310395803"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Miyatani T, Kurita N, Komatsu M, Sato H, Yoshikawa K, Higashijima J et al. (2013) The investigation for characteristics of patients with antiphospholipid antibody syndrome. J Jap College Surgeons 38, 759-764.","DOI":"10.4030\/jjcs.38.759"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Friedman RJ, Schiff CF, Bromberg JS (1995) Use of supplemental steroids in patients having orthopedic operations. J Bone Joint Surg 77A, 1801-1806.","DOI":"10.2106\/00004623-199512000-00002"}],"container-title":["Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/61\/3\/61_18-0164\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T03:53:46Z","timestamp":1567223626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/josnusd\/61\/3\/61_18-0164\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2334\/josnusd.18-0164","relation":{},"ISSN":["1343-4934","1880-4926"],"issn-type":[{"value":"1343-4934","type":"print"},{"value":"1880-4926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}